期刊文献+

人TLT-2真核表达载体的构建及其在L929细胞株中的稳定转染

Construction of Eukaryotic Expressing Vector of Human TLT-2 and Establishment of Stable Transfectant L929 Cell Line
原文传递
导出
摘要 目的构建含有人TLT-2基因的真核表达载体,并通过转染获得稳定表达TLT-2分子的L929转基因细胞株。方法运用逆转录聚合酶链式反应(RT-PCR)技术从健康人外周血单个核细胞(PBMC)的cDNA文库获得全长TLT-2基因,经过双酶切(XhoI和EcoRI)装入逆转录病毒表达载体pIRES2-EGFP中,脂质体法转染L929细胞,经G418抗性筛选,流式细胞术、RT-PCR及Western blot鉴定TLT-2分子的表达。结果构建了真核表达载体pIRES2-EGFP/hTLT-2,建立了稳定转染TLT-2目的基因的L929细胞株。结论成功构建了TLT-2真核表达载体并获得了稳定转染该分子的转基因细胞,为进一步研究人TLT-2分子的生物学功能提供了物质基础。 Objective To construct eukaryotic expressing vector of human trem-like transcript 2(TLT-2) gene and transfect L929 cells so as to establish stable L929 cell line.Methods cDNA fragment encoding TLT-2 was obtained from human lymphocyte cells by reverse transcription.The TLT-2 gene was then designed with the restiction endonucleases XhoI and EcoRI and inserted into corresponding region of pIRES2-EGFP vector.And then the recombinant pIRES2-EGFP/TLT-2 was transfected into L929 cells by lipofectanime TM2000.After screening culture by G418,stable transfected L929 cell line was established,and the expression of TLT-2 was identified by FCM,RT-PCR and Western blot.Results The eukaryotic expressing vector pIRES2-EGFP/TLT-2 was constructed,stable transfected L929 cell line was established,and TLT-2 gene was expressed successfully.Conclusion The construction of eukaryotic expressing vector pIRES2-EGFP/TLT-2 and the development of stable transfected L929 cells have provided a solid experiment foundation for further studies of TLT-2 fuction.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2011年第3期376-379,共4页 Suzhou University Journal of Medical Science
基金 国家自然科学基金资助项目(K1134974) 江苏省临床免疫学重点实验室基金资助项目
关键词 TLT-2基因 真核表达载体 转染 L929细胞 TLT-2 eukaryotic expressing vector transfection L929 cell line
  • 相关文献

参考文献8

  • 1Medzhitov R. Toll-like receptor and innate inmmnity [ J ]. Nature Rev Immunol,2001,1 (2) :135 -145.
  • 2Jill WF, Daniel WM. TREM and TREM-like receptors in inflammation and disease [ J ]. Current Opinion in Immuno logy,2009,21 (5) : 1 - 9.
  • 3Richard JN, Allcock ABD, Forbes S. The human TREM gene cluster at 6p21.1 encodes both activating and inhibi- tory single IgV domain receptors and includes NKp44 [ J ]. Eur J Immunol,2003,33 (6) : 567 - 577.
  • 4King RG, Brantley RH. TREM-like transcript 2 (TLT-2) is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflam- mation [J]. The Journal of Immunology,2006,176( 10): 6012 - 6021.
  • 5陈永井,施勤,葛彦,徐宽枫,古涛,孙建军,李文香,张学光.人PD-L1(B7-H1)基因克隆及其逆转录病毒载体的构建和稳定表达[J].中国肿瘤生物治疗杂志,2003,10(2):110-114. 被引量:7
  • 6Hashiguchi M, Kobori H. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-recep- tor for B7-H3 and enhances T cell responses [ J ]. Proc Natl Acad Sci USA,2008,105 (30) : 10495 - 10500.
  • 7Kobori H, Hashiguchi M. Piao J. Enhancement of effector CD8 ( + ) T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor ex- pressed on myeloid cell-like transcript 2 at tumour sites [ J ]. Immunology, 2010,130 (3) :363 - 373.
  • 8Leitner J, Klauser C, Pickl WF. B7-H3 is a potent inhibi- tor of human T-cell activation :no evidence for B7-H3 and TREML2 interaction[ J ]. European Journal of Immunology, 2009,39 ( 7 ) : 1754 - 1764.

二级参考文献12

  • 1Iwai Y, Ishida M, Tanaka Y, et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade [J ]. Proc Natl Acad Sci USA,2002, 99(19) : 12293-12297.
  • 2Mazanet MM, Hughes CC. B7-h1 is expressed by human endothelial cells and suppresses T cell cytokine synt-hesis [J ]. J Immunol, 2002, 169(7) : 3581-3588.
  • 3Lanzavecchia A, Lezzi G, Viola A. From TCR engagement to T cell activation: A kinetic view of T cell behavior[J]. Cell, 1999,96(1): 1-4.
  • 4Schwartz R H. A cell culture mode for T lymphocyte clonal anergy[J]. Science, 1990, 4961: 1349-1356.
  • 5Chambers CA. The expanding world of co-stimulation: The two-signal model revisited[ J]. Trends Immunol, 2001,22(4) : 217-223.
  • 6Freeman GF, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphcyte activation[J]. J Exp Med, 2000,192 (7): 1027-1034.
  • 7Latchman Y, Wood CR, Chernnova C, et al. PD-L2 is a second ligand for PD-1 and inhibit T cell activation [ J ]. Nat Immunol,2001,2 (3) : 261-267.
  • 8Carter L, Fouser LA, Jussif J, et al. PD-1 : PD-L inhibitory pathway affects both CD4^+ and CD8^+ T cells and is overcomed by IL-2[J]. Eur J Immunol, 2002, 32: 634-643.
  • 9Nishimura H, Honjo T. PD-1 : An inhibitory immunoreceptor involved in peripheral tolerance[ J]. Trends in Immunol, 2001, 22(5) : 265-268.
  • 10Dong HD, Zhu G, Tamada K, et al. BT-H1, a third member of the B7 family,co-stimulates T-cel proliferation and interleukin-10 secretion[J]. Nat Med, 1999, 5 (12) : 1365-1369.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部